Jump to navigation
Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
Titled, “New chapter unfolding in the fight against dengue with an unwritten ending,” the Dengue Vaccine Initiative’s (DVI) editorial just published in the October issue of Transactions
This blog post was originally published by the Dengue Vaccine Initiative (DVI).
This blog post was originally published by the Dengue Vaccine Initiative (DVI). Please click